Ocular Therapeutix, Inc. (OCUL)
8.63
-0.13
(-1.48%)
USD |
NASDAQ |
Mar 16, 16:00
8.61
-0.02
(-0.23%)
After-Hours: 20:00
Ocular Therapeutix Market Cap : 1.879B for March 16, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Regeneron Pharmaceuticals, Inc. | 80.02B |
| Abbott Laboratories | 191.06B |
| EyePoint Plc | 1.122B |
| Quince Therapeutics, Inc. | 5.791M |
| Ernexa Therapeutics, Inc. | 2.372M |
Market Cap Related Metrics
| PS Ratio | 31.10 |
| PEG Ratio | -0.4284 |
| Price to Book Value | 2.871 |
| Price | 8.63 |
| Earnings Yield | -16.67% |
| PEGY Ratio | -0.4284 |